CFO
XRAY icon

CVA Family Office’s Dentsply Sirona XRAY Stock Holding History

CVA Family Office’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$520 Sell
49
-288
-85% -$3.15K ﹤0.01% 1730
2026
Q1 		$3.91K Buy
337
+212
+170% +$2.64K ﹤0.01% 1318
2025
Q4 		$1.43K Buy
+125
New +$1.47K ﹤0.01% 1041
2025
Q3 		– Sell
-78
Closed -$1.24K – 1350
2025
Q2 		$1.24K Sell
78
-46
-37% -$688 ﹤0.01% 1060
2025
Q1 		$1.85K Buy
+124
New +$2.2K ﹤0.01% 1019
2023
Q3 		– Sell
-95
Closed -$3.8K – 981
2023
Q2 		$3.8K Hold
95
– – ﹤0.01% 832
2023
Q1 		$3.73K Buy
95
+75
+375% +$2.75K ﹤0.01% 808
2022
Q4 		$637 Buy
+20
New +$603 ﹤0.01% 888
2022
Q3 		– Sell
-75
Closed -$3K – 948
2022
Q2 		$3K Sell
75
-205
-73% -$8.29K ﹤0.01% 813
2022
Q1 		$14K Hold
280
– – ﹤0.01% 630
2021
Q4 		$16K Buy
+280
New +$15.4K ﹤0.01% 567
2021
Q3 		– Sell
-140
Closed -$9K – 904
2021
Q2 		$9K Hold
140
– – ﹤0.01% 687
2021
Q1 		$9K Buy
+140
New +$8.12K ﹤0.01% 542

Other funds holding XRAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

CVA Family Office's XRAY Position: Q2 2026 in Review

CVA Family Office reduced its Dentsply Sirona (XRAY) stake by 85% in Q2 2026, selling an estimated $3.15K and leaving 49 shares worth $520. The position accounts for ﹤0.01% of the portfolio, ranked #1730.

CVA Family Office first reported a position in XRAY in Q1 2021 and has held it in 13 quarters since. The position peaked at $16K in Q4 2021. 374 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • CVA Family Office held 49 shares of Dentsply Sirona worth $520 as of Q2 2026.
  • CVA Family Office sold 288 Dentsply Sirona shares in Q2 2026, an estimated $3.15K.
  • Dentsply Sirona made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1730 holding.
  • CVA Family Office first reported a position in Dentsply Sirona in Q1 2021 and has held it in 13 quarters since.
  • CVA Family Office's Dentsply Sirona position peaked at $16K in Q4 2021.
  • 374 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.